{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:35:45Z","timestamp":1791362145716,"version":"4.3.1"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"16","license":[{"start":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T00:00:00Z","timestamp":1682035200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,4,21]]},"abstract":"<jats:p>\n                    Chemotherapy-induced peripheral neuropathy (CIPN) is a serious side effect of weekly paclitaxel-based chemotherapy for breast cancer, that can persist for years. Cryotherapy therapy is effective for preventing early CIPN, but its protective effect on persistent CIPN is uncertain. This is a cross-sectional study conducted as an ancillary analysis of a randomized trial investigating the preventive effect of cryotherapy on CIPN in breast cancer patients receiving weekly paclitaxel-based chemotherapy (UMIN000034966). Eligible patients were evaluated for CIPN at more than a year after completion of the chemotherapy (persistent CIPN). CIPN was defined as a 6 or more points reduction from baseline in the Functional Assessment of Cancer Therapy-Neurotoxicity (FACT-NTX) score. The incidence of early and persistent CIPN was compared between cryotherapy and control groups. Thirty-eight patients were examined for both early and persistent CIPN. The median time from completion of the weekly paclitaxel-based chemotherapy to the questionnaire for persistent CIPN was 2.3 (1.3\u20133.1) years. In all 38 patients, persistent CIPN was demonstrated in 10 (26.3%), respectively. There was a numerical, however not significant, reduction in the incidence of persistent CIPN (15.8% vs 36.8%,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = .1) in the cryotherapy group compared with the control group, respectively. In multivariate logistic regression analysis, age \u2265 65 was a substantial risk factor for persistent CIPN (HR: 14.7, 95%CI: 1.7\u2013130.7,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = .01). In breast cancer patients receiving adjuvant weekly paclitaxel-based chemotherapy, cryotherapy resulted in a numerical, however not significant, reduction in the incidence of persistent CIPN and age&gt;=65 was a risk factor for persistent CIPN.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000033580","type":"journal-article","created":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T11:30:32Z","timestamp":1682076632000},"page":"e33580","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Persistent weekly paclitaxel-induced peripheral neuropathy in early breast cancer patients enrolled in a randomized trial of cryotherapy"],"prefix":"10.1097","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9393-9655","authenticated-orcid":false,"given":"Hideo","family":"Shigematsu","sequence":"first","affiliation":[{"name":"Department of Breast Surgery, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, 3-1, Aoyama-cho, Kure-City, Hiroshima 737-0023, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, 3-1, Aoyama-cho, Kure-City, Hiroshima 737-0023, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Itagaki","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, 3-1, Aoyama-cho, Kure-City, Hiroshima 737-0023, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Yasui","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, 3-1, Aoyama-cho, Kure-City, Hiroshima 737-0023, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1200\/JCO.20.01399","article-title":"Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update.","volume":"38","author":"Loprinzi","year":"2020","journal-title":"J Clin Oncol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"e2239788","DOI":"10.1001\/jamanetworkopen.2022.39788","article-title":"Association of taxane type with patient-reported chemotherapy-induced peripheral neuropathy among patients with breast cancer.","volume":"5","author":"Mo","year":"2022","journal-title":"JAMA Netw Open"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s10549-010-1278-0","article-title":"Association between patient reported outcomes and quantitative sensory tests for measuring long-term neurotoxicity in breast cancer survivors treated with adjuvant paclitaxel chemotherapy.","volume":"125","author":"Hershman","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s10147-011-0352-x","article-title":"Paclitaxel-induced peripheral neuropathy in patients receiving adjuvant chemotherapy for breast cancer.","volume":"18","author":"Tanabe","year":"2013","journal-title":"Int J Clin Oncol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/jama.2013.2813","article-title":"Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial.","volume":"309","author":"Smith","year":"2013","journal-title":"JAMA"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s40261-019-00882-6","article-title":"Comparison of the efficacy and safety of pregabalin and duloxetine in taxane-induced sensory neuropathy: a randomized controlled trial.","volume":"40","author":"Salehifar","year":"2020","journal-title":"Clin Drug Investig"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.3747\/co.26.4261","article-title":"A systematic review of acupuncture for chemotherapy-induced peripheral neuropathy.","volume":"26","author":"Li","year":"2019","journal-title":"Curr Oncol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s00520-019-04881-3","article-title":"Scrambler therapy for chemotherapy neuropathy: a randomized phase II pilot trial.","volume":"28","author":"Loprinzi","year":"2020","journal-title":"Support Care Cancer"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s11764-021-00997-w","article-title":"A systematic review of behavioural and exercise interventions for the prevention and management of chemotherapy-induced peripheral neuropathy symptoms.","volume":"17","author":"Tanay","year":"2023","journal-title":"J Cancer Surviv"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.annonc.2020.07.003","article-title":"Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO-EONS-EANO clinical practice guidelines for diagnosis, prevention, treatment and follow-up.","volume":"31","author":"Jordan","year":"2020","journal-title":"Ann Oncol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/jnci\/djx178","article-title":"Effects of cryotherapy on objective and subjective symptoms of paclitaxel-induced neuropathy: prospective self-controlled trial.","volume":"110","author":"Hanai","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10549-016-3977-7","article-title":"Evaluation of the effect of compression therapy using surgical gloves on nanoparticle albumin-bound paclitaxel-induced peripheral neuropathy: a phase II multicenter study by the Kamigata Breast Cancer Study Group.","volume":"160","author":"Tsuyuki","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1038\/bjc.2014.466","article-title":"Subgroup effects in a randomised trial of different types and doses of exercise during breast cancer chemotherapy.","volume":"111","author":"Courneya","year":"2014","journal-title":"Br J Cancer"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s00520-017-4013-0","article-title":"Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial.","volume":"26","author":"Kleckner","year":"2018","journal-title":"Support Care Cancer"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1007\/s00520-020-05345-9","article-title":"Cryotherapy for the prevention of weekly paclitaxel-induced peripheral adverse events in breast cancer patients.","volume":"28","author":"Shigematsu","year":"2020","journal-title":"Support Care Cancer"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/cncr.11578","article-title":"Measuring the side effects of taxane therapy in oncology: the functional assesment of cancer therapy-taxane (FACT-taxane).","volume":"98","author":"Cella","year":"2003","journal-title":"Cancer"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"djw206","DOI":"10.1093\/jnci\/djw206","article-title":"BMI, lifestyle factors and taxane-induced neuropathy in breast cancer patients: the pathways study.","volume":"109","author":"Greenlee","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1212\/01.WNL.0000043691.53710.53","article-title":"Toxic neuropathy in patients with pre-existing neuropathy.","volume":"60","author":"Chaudhry","year":"2003","journal-title":"Neurology"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1200\/JCO.2012.44.8738","article-title":"Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy.","volume":"31","author":"Hershman","year":"2013","journal-title":"J Clin Oncol"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/jnci\/djx259","article-title":"Two-year trends of taxane-induced neuropathy in women enrolled in a randomized trial of acetyl-L-carnitine (SWOG S0715).","volume":"110","author":"Hershman","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1200\/JCO.2015.66.2346","article-title":"Comorbidities and risk of chemotherapy-induced peripheral neuropathy among participants 65 years or older in southwest oncology group clinical trials.","volume":"34","author":"Hershman","year":"2016","journal-title":"J Clin Oncol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000033580","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T21:22:31Z","timestamp":1746307351000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000033580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,21]]},"references-count":21,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000033580","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,21]]}}}